Nephrotic syndrome after treatment with pamidronate

Am J Kidney Dis. 2002 May;39(5):1118-22. doi: 10.1053/ajkd.2002.32797.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Diphosphonates / administration & dosage
  • Diphosphonates / adverse effects*
  • Diphosphonates / therapeutic use
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Humans
  • Injections, Intravenous
  • Multiple Myeloma / diagnosis
  • Multiple Myeloma / drug therapy
  • Nephrotic Syndrome / chemically induced*
  • Nephrotic Syndrome / diagnosis*
  • Nephrotic Syndrome / pathology
  • Pamidronate

Substances

  • Antineoplastic Agents
  • Diphosphonates
  • Pamidronate